GlassScriptPhysician profile
Winston D Shipley
NPI 1154393163
$10,629.18
in general payments reported to CMS, 2019-2025
56 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,524 · 2020: $1,462 · 2021: $2,072 · 2022: $1,940 · 2023: $1,260 · 2024: $1,124 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,595 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,594.63 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,912.48 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Novartis Pharmaceuticals Corporation | $1,389.93 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $608.92 | 2019-2021 | |
| Genzyme Corporation | $471.20 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $432.66 | 2020-2023 | Nuplazid |
| Biogen, INC. | $392.09 | 2019-2025 | Tysabri, Vumerity |
| Sunovion Pharmaceuticals INC. | $377.69 | 2019-2022 | |
| Allergan, INC. | $373.08 | 2019-2021 | |
| Ucb, INC. | $345.45 | 2021-2023 | Briviact, Nayzilam |
| Celgene Corporation | $324.91 | 2020-2025 | Zeposia |
| Pfizer INC. | $269.95 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $261.37 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $247.77 | 2021 | |
| Eisai INC. | $211.02 | 2021-2024 | |
| Lundbeck LLC | $203.09 | 2019-2025 | Vyepti, Rexulti |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Shipley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.